focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLID.L Regulatory News (LID)

  • There is currently no data for LID

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Confirmation of CFO appointment & Award of options

6 Jul 2017 07:00

RNS Number : 2639K
LiDCO Group Plc
06 July 2017
 

LiDCO Group Plc

("LiDCO" or the "Company")

 

Confirmation of Chief Financial Officer appointment

 

Award of share options/director dealing

 

LiDCO (AIM: LID), the hemodynamic monitoring company, confirms the appointment of Jill McGregor as Chief Financial Officer on the 3 July, further to the announcement made on the 1 March 2017.

 

Ms McGregor is a Chartered Accountant and has over 25 years' experience in a number of finance roles. Ms McGregor joins LiDCO after six years as Chief Financial Officer of Touch Bionics, a UK based provider of upper limb technologies, with operations in the USA and Germany which was recently acquired by Össur. Prior to this, Ms McGregor spent seven years at Optos plc, a provider of retinal imaging devices, as Group Financial Controller and then as Vice President and Director of Finance. Optos listed on the London Stock Exchange in 2006 and was acquired by Nikon in 2015.

 

Grant of options

Yesterday, 5 July 2017, the Company finalised a grant of options ("Options") to Jill McGregor, CFO, to subscribe for new ordinary shares of 0.5p each ("Ordinary Shares").

 

 

Option type

Number of shares over which options granted

Total number of options held post grant

Percentage of issued share capital under option

Jill McGregor

EMI

1,500,000

1,500,000

0.6%

 

 

 

 

 

Total

 

1,500,000

1,500,000

0.6%

 

The above Options vest and may be exercised three years from grant if certain share price hurdles are met. The Options are exercisable over a range of periods at 0.5 pence per Ordinary Share, subject to the Company's share price averaging above a number of hurdle rates. The hurdle rates were in part set with regard to yesterday's closing share price of 10.125p and are between 12p and 16p.

 

The below notification is made in accordance with the requirements of the EU Market Abuse Regulation.

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Jill McGregor

2.

Reason for the notification

a)

Position/status:

Chief Financial Officer

b)

Initial notification/Amendment:

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

LiDCO Group Plc

b)

LEI:

n/a

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary Shares of 0.5p nominal

 

GB0030546849

b)

Nature of the transaction:

Grant of Management Share Options

c)

Price(s) and volume(s):

 

Price(s)

Volume(s)

0.5p

1,500,000

d)

Aggregated information:

· Aggregated volume:

· Price:

Single transaction as in 4 c) above

Price(s)

Volume(s)

0.5p

1,500,000

e)

Date of the transaction:

05/07/17

f)

Place of the transaction:

London Stock Exchange, AIM (XLON)

 

 

For further information, please contact:

 

LiDCO Group Plc

www.lidco.com

Matt Sassone (CEO)

Tel: +44 (0)20 7749 1500

finnCap

Tel: +44 (0)20 7600 1658

Geoff Nash / Emily Watts (Corporate Finance)

Stephen Norcross (Corporate Broking)

Walbrook PR Ltd

Tel: 020 7933 8780 or lidco@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCXELLBDDFXBBX
Date   Source Headline
26th Jan 20064:38 pmPRNConvertible loan update
19th Jan 20067:00 amRNSProduct Development
19th Dec 20051:15 pmPRNResignation of a Director
8th Dec 20059:02 amPRNDirector Shareholding
18th Nov 20057:00 amRNSConversion of Loan
8th Nov 20057:01 amRNSPositive Study Data
3rd Nov 20057:00 amRNSUS Army Order
25th Oct 20057:01 amRNSClinical Advisory Board
18th Oct 20057:01 amRNSInterim Results
14th Oct 20051:39 pmPRNDirectorate Change
26th Sep 20059:11 amRNSNotice of Results
11th Aug 20057:02 amRNSUSD 2 Million Financing
14th Jul 20057:00 amRNSAdditional Listing
7th Jul 20057:01 amRNSNew Veterinary Application
23rd Jun 20054:00 pmRNSImpact of Review Paper
17th Jun 20057:00 amRNSBoard Appointment
16th Jun 20052:57 pmRNSAGM Statement
6th Jun 20052:38 pmPRNDirector Shareholding
1st Jun 20057:00 amRNSPositive Data
10th May 20052:20 pmPRNDirector Shareholding
9th May 20057:00 amRNSRegistration in Brazil
25th Apr 20057:00 amRNSAppointment of New Director
15th Apr 200511:46 amRNSDirector Shareholding
13th Apr 20057:00 amRNSDirector Share Options Award
7th Apr 20057:00 amRNSDirector Shareholding
30th Mar 20057:01 amRNSPreliminary Results
30th Mar 20057:01 amRNSProduct Approval in Denmark
24th Mar 20057:02 amRNSLaunch Of Software Upgrade
23rd Mar 200510:50 amPRNAdditional Listing
21st Mar 20057:02 amRNSSignificant Trial Results
15th Mar 20057:02 amRNSEuropean Approval
2nd Mar 20058:19 amRNSChange of Financial PR Agency
14th Feb 20057:00 amPRNMajor Clinical Trial
24th Jan 20053:25 pmPRNAdditional Listing
19th Jan 20054:16 pmPRNDirectorate Change
13th Jan 200511:28 amPRNAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.